The long-term acceptance of organ allografts can be induced in numerous rod
ent and some preclinical outbred models. Induction methods can use donor al
loantigen in various forms, including spontaneous acceptance of grafts such
as livers, to deviate the immune response so a subsequent graft will be ac
cepted. Establishment of lymphohemopoietic chimerism is not essential. Shor
t-term immunosuppressive treatments that prevent acute rejection can also i
nduce tolerance. These include nonspecific immunosuppressive drugs and immu
notherapy that blocks cell surface molecular interactions or cytokine funct
ion. There is variation in the effect of these protocols on different strai
n combinations that may be due to innate differences in the cell subpopulat
ions and cytokines activated in the hosts. Th1 cytokines, although importan
t in the mediation of rejection, are also required for induction of toleran
ce. Th2 cytokines may facilitate tolerance induction but are not essential.
The tolerant state takes weeks to fully mature after exposure to alloantig
en. Tolerance is associated with a loss or change in dendritic cells and th
e development of suppressor cells, which in all cases include CD4+ T cells.
In the near future precise understanding of the function of these two cell
types may allow diagnosis and induction of tolerance in clinical transplan
tation.